Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare

May 1, 2024

https://www.globenewswire.com/news-release/2024/05/01/2873591/0/en/Elevai-Labs-Expands-with-Launch-of-Elevai-Biosciences-and-Elevai-Skincare-Subsidiaries-Advancing-the-Future-of-Aesthetic-Medicines-and-Exosome-Skincare.html

NEWPORT BEACH, Calif., May 01, 2024 (GLOBE NEWSWIRE) — Elevai Labs, Inc. (NASDAQ:ELAB) (“Elevai” or the “Company”), a pioneering force in medical aesthetics, today announced the establishment of two new wholly owned subsidiaries, Elevai Biosciences, Inc., and Elevai Skincare, Inc. These ventures mark a strategic shift towards the development of next-generation aesthetic medicines and efforts to improve the economics of its commercialized exosome skincare brand.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.